- Report
- November 2025
- 374 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 484 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 471 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 461 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 566 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 191 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 269 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 263 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 172 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 188 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 184 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 462 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 293 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 158 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 504 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 158 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 200 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 323 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 227 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 221 Pages
Global
From €5256EUR$5,850USD£4,637GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more